![PRD_000144 PRD_000144](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000144.svg) | PRD_000144 | Name: | Cyclosporin C | Formula: | C62 H111 N11 O13 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS
FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000150 PRD_000150](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000150.svg) | PRD_000150 | Name: | GRAMICIDIN A | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000151 PRD_000151](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000151.svg) | PRD_000151 | Name: | GRAMICIDIN B | Formula: | C97 H139 N19 O17 | Description: | GRAMICIDIN B IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000152 PRD_000152](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000152.svg) | PRD_000152 | Name: | GRAMICIDIN D | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN D IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 1).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000153 PRD_000153](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000153.svg) | PRD_000153 | Name: | GRAMICIDIN C | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN C IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000154 PRD_000154](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000154.svg) | PRD_000154 | Name: | MINI-GRAMICIDIN A DIMER | Formula: | C168 H226 N32 O26 | Description: | THE N-TERMINI OF THE TWO IDENTICAL PEPTIDES, EACH
A TRUNCATED GRAMICIDIN A WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000155 PRD_000155](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000155.svg) | PRD_000155 | Name: | MINI-GRAMICIDIN A - GRAMICIDIN A DIMER | Formula: | C180 H244 N34 O30 | Description: | THE N-TERMINI OF THE TWO PEPTIDES, EACH A
TRUNCATED GRAMICIDIN A, WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000156 PRD_000156](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000156.svg) | PRD_000156 | Name: | Cephaibol A | Formula: | C82 H127 N17 O20 | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000937 PRD_000937](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000937.svg) | PRD_000937 | Name: | peptide inhibitor | Formula: | C33 H50 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000157 PRD_000157](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000157.svg) | PRD_000157 | Name: | Cephaibol B | Formula: | C83 H129 N17 O20 | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000158 PRD_000158](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000158.svg) | PRD_000158 | Name: | Cephaibol C | Formula: | C82 H127 N17 O20 | Description: | CEPHAIBOL C IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000159 PRD_000159](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000159.svg) | PRD_000159 | Name: | Zervamicin IIB | Formula: | C90 H139 N19 O22 | Description: | ZERVAMICIN IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000160 PRD_000160](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000160.svg) | PRD_000160 | Name: | TRICHOTOXIN A50E | Formula: | C78 H136 N20 O21 | Description: | TRICHOTOXIN_A50E IS AN OCTADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000161 PRD_000161](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000161.svg) | PRD_000161 | Name: | Antiamoebin 1 | Formula: | C82 H127 N17 O20 | Description: | ANTIAMOEBIN I IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000162 PRD_000162](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000162.svg) | PRD_000162 | Name: | Chrysospermin-C | Formula: | C91 H142 N22 O23 | Description: | CHRYSOSPERMIN C IS A NONADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000944 PRD_000944](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/OEU.svg) | PRD_000944 | Name: | N-{(2S)-1-[(2-chlorobenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[3-(2-methylphenyl)propanoyl]-L-threoninamide | Formula: | C31 H36 Cl N3 O4 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000163 PRD_000163](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000163.svg) | PRD_000163 | Name: | Alamethicin | Formula: | C92 H150 N22 O25 | Description: | ALAMETHICIN F30 IS AN EICOSAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000946 PRD_000946](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/23X.svg) | PRD_000946 | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-isoleucinamide | Formula: | C30 H42 N4 O5 S2 | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000180 PRD_000180](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000180.svg) | PRD_000180 | Name: | Antipain | Formula: | C27 H46 N10 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000947 PRD_000947](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/F72.svg) | PRD_000947 | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | Formula: | C31 H35 N3 O5 S2 | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000183 PRD_000183](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000183.svg) | PRD_000183 | Name: | Microcin C7 | Formula: | C28 H49 N12 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000948 PRD_000948](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/A69.svg) | PRD_000948 | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(3-phenylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | Formula: | C33 H33 N3 O5 S2 | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000184 PRD_000184](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000184.svg) | PRD_000184 | Name: | Microcin J25 | Formula: | C101 H140 N23 O27 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000949 PRD_000949](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/F71.svg) | PRD_000949 | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-([(2S)-2-methylbutyl]{[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino)-1-phenylbutan-2-yl]benzamide | Formula: | C29 H33 N3 O6 S2 | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000950 PRD_000950](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/55A.svg) | PRD_000950 | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-leucinamide | Formula: | C30 H42 N4 O5 S2 | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|